Skip to main content
OpenTrials
Completed

NCT Number: NCT04694664

COVID-19 Vaccine Confidence Among Pregnant Women and Mothers

The purpose of this study is to assess the level of vaccine confidence and influencers among pregnant women and mothers of school-aged children during the COVID-19 pandemic.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

Female

Study type

Observational

Primary location

Pregistry

Los Angeles, California, 90067, United States

About this study

The WHO has listed "vaccine hesitancy" as one of the top threats to global health.

The COVID-19 pandemic has triggered the need to vaccinate worldwide as soon as a safe and efficacious vaccine becomes available. However preliminary data show that, on average, only 50% to 66% of US adults would be willing to receive COVID-19 vaccination when it becomes available, a percentage lower than what is required for herd immunity to control the pandemic. Furthermore, there is a pressing need to vaccinate children to reopen schools and keeping them safe, as well as to immunize pregnant women through vaccination programs since they constitute a vulnerable population. Vaccine confidence among pregnant women and mothers of school-aged children during the period of COVID-19 pandemic is unknown, leading to an important gap of knowledge that may hinder the upcoming global COVID-19 vaccination scale-up effort. It is therefore of critical importance to assess the level of vaccine confidence and influencers among pregnant women and mothers of school-aged children during the COVID-19 pandemic.

The international nature of the proposed survey will allow the evaluation of vaccine confidence and its influencers among pregnant women and mothers of school-aged children on a global level. Therefore, social and geographic characteristics from different countries and cultures will be available for comparison. The resulting knowledge will be relevant to a large percentage of the world's population. Any country in the world can participate.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant women or women who have at least one child younger than 18 years of age. Able to give electronic informed consent

Exclusion criteria

  • <18 years of age

Treatment and study plan

This is an online survey with no intervention.

Other

As this is an online survey about health and wellbeing, there is no intervention.

Primary outcomes

  1. Percentage of acceptance of a COVID-19 vaccine

    Time frame: up to 2 months

    This outcome will evaluate the hesitancy or acceptance to a COVID-19 vaccine

Sponsors and collaborators

Lead sponsor

Pregistry

Industry

Collaborators

  • Harvard School of Public Health (HSPH)

Registry information

Official study title

Vaccine Confidence Among Pregnant Women and Mothers During the COVID-19 Pandemic

Acronym: VCCOVID

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jan 5, 2021
Registry last updated
Jan 5, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.